Gene-Disorder Association · Article
Gene
ALKALK Receptor Tyrosine Kinase
×
First reported
2008
Supporting publications
2
Manually curatedApproved treatment annotated
Association Review
In brief
The association between ALK (ALK Receptor Tyrosine Kinase) and Sarcoma is reported, with clinical genetic testing available.
Sources
1
Clinical variants
0
Symptoms
0
Compounds
4
Trials
126of 3,690 via ALK compounds
Publications
2
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Interventions
Therapeutics
4 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
06
Human studies
Clinical trials
3,690 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
2 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
08
Provenance
References & sources
8 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access